search query: @indexterm BIO-TECHNOLOGY INDUSTRY / total: 101
references: 43-52 / 101
« previous page | next page »
 titleyearauthor
43.
Manage polarities before they manage you
Research Technology Management
2001 : SEP-OCT, VOL. 44:5, p. 58-60
 2001 Hirschhorn, L.
44.
Scenarios on the future of biotechnology
Technological Forecasting and Social Change
2001 : OCT, VOL. 68:2, p. 109-129
 2001 Sager, B.
45.
Technology management and collaboration profile: virtual companies and industrial platforms in the high- tech biotechnology industries
R. and D. Management
2001 : VOL. 31:1, p. 91-100
 2001 Weisenfeld, U.
Reeves, J. C.
Hunck-Meiswinkel, A.
46.
Drug discovery and development in four Canadian biotech companies
R. and D. Management
2001 : VOL. 31:1, p. 77-90
 2001 Tapon, F.
Thong, M.
Bartell, M.
47.
Management of Intellectual Property Rights in European Biotechnology Firms
Technological Forecasting and Social Change
2001 : JUN-JUL, VOL. 67:2-3, p. 259-272
 2001 Thumm, N.
48.
Agricultural Biotechnology in the European Union: Alternative Technologies and Economic Outcomes
Technology analysis & strategic management
2001 : JUN, VOL. 13:2, p. 265-280
 2001 Arundel, A.
49.
Closing the innovative loop: moving from the laboratory to the shop floor in biotechnology manufacturing
Entrepreneurship & Regional Development
2001 : JAN-MAR, VOL. 13:1, p. 1-16
 2001 Feldman, M. P.
Ronzio, C. R.
50.
Hot Potato, Hot Potato: Regulating Products of Biotechnology by the International Community
Journal of World Trade
2001 : FEB, VOL. 35:1, p. 1-32
 2001 Buckingham, D. E.
Phillips, P. W. B.
51.
Alternative paradigms -- the WTO versus the biosafety protocal for trade in generally modified organisms
Journal of World Trade
2000 : AUG, VOL. 34:4, p. 63-75
 2000 Phillips, P.
Kerr, W.
52.
Real-options valuation for a biotechnology company
Financial Analysts' Journal
2000 : MAY-JUN, VOL. 56:3, p. 76-87
 2000 Charnes, J.M.
Kellogg, D.
« previous page | next page »
SCIMA